Cukup Tau
By : Rizky Febian
Intro : D C#m Bm A
D C#m
sunggu percuma saja
Bm A
ku mencintainya tapi tak dicintai
D C#m
gerak tubuhnya seolah berkata
Bm A
tak cinta padaku dan tak suka padaku
D C#m
aku pun mulai berpikir
Bm E
ku sakit hati dan mulai ku merasa
Chorus :
D
cukup tau tanam dalam diri
C#m
tak usah ku dekatimu lagi
Bm
ku ta mau lagi tak mau lagi
F#m
bersamamu kasih
D
cukup tau tanam dalam diri
C#m
tak usah ku ganggu kamu lagi
Bm E
ku tak mau lagi tak mau lagi sayang
Int : D C#m Bm A
D C#m
gerak tubuhnya seolah berkata
Bm A
tak cinta padaku dan tak suka padaku
D C#m
aku pun mulai berpikir
Bm E
ku sakit hati dan mulai ku merasa
Chorus :
D
cukup tau tanam dalam diri
C#m
tak usah ku dekatimu lagi
Bm
ku ta mau lagi tak mau lagi
F#m
bersamamu kasih
D
cukup tau tanam dalam diri
C#m
tak usah ku ganggu kamu lagi
Bm E
ku tak mau lagi tak mau lagi sayang
Solo : D C#m Bm A 2x
Chorus :
D
cukup tau tanam dalam diri
C#m
tak usah ku dekatimu lagi
Bm
ku ta mau lagi tak mau lagi
F#m
bersamamu kasih
D
cukup tau tanam dalam diri
C#m
tak usah ku ganggu kamu lagi
Bm E
ku tak mau lagi tak mau lagi sayang
D
cukup tau tanam dalam diri
C#m
tak usah ku dekatimu lagi
Bm
ku ta mau lagi tak mau lagi
F#m
bersamamu kasih
D
cukup tau tanam dalam diri
C#m
tak usah ku ganggu kamu lagi
Bm E
ku tak mau lagi tak mau lagi sayang
Outro : D C#m Bm A
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment